NCT04569591 2026-03-18
DDAVP for Pituitary Adenoma
National Institutes of Health Clinical Center (CC)
Phase NA Recruiting
Clinical Trials
3 trialsNCT05971758 2025-07-04
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
University of California, Los Angeles
Phase 2 Recruiting
NCT05804669 2025-04-10
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Crinetics Pharmaceuticals Inc.
Phase 1/2 Recruiting